Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
140.14B | 144.18B | 124.96B | 110.78B | 99.97B | 118.97B | Gross Profit |
33.94B | 33.03B | 27.41B | 24.56B | 19.95B | 23.12B | EBIT |
12.99B | 13.89B | 10.84B | 10.11B | 7.29B | 9.60B | EBITDA |
17.99B | 26.64B | 13.78B | 12.79B | 9.87B | 12.14B | Net Income Common Stockholders |
10.59B | 15.28B | 8.31B | 5.31B | 2.11B | 5.55B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
23.43B | 21.38B | 18.32B | 16.89B | 15.72B | 13.00B | Total Assets |
192.35B | 155.14B | 143.90B | 119.71B | 110.20B | 110.25B | Total Debt |
60.43B | 28.08B | 34.30B | 22.85B | 13.68B | 14.74B | Net Debt |
39.73B | 8.56B | 15.98B | 5.97B | -31.00M | 1.75B | Total Liabilities |
101.64B | 68.17B | 72.48B | 56.47B | 39.87B | 43.53B | Stockholders Equity |
86.13B | 83.42B | 68.11B | 60.17B | 60.68B | 58.01B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.05B | 3.65B | 5.96B | 5.01B | 3.43B | Operating Cash Flow |
0.00 | 11.75B | 10.28B | 9.49B | 9.33B | 7.77B | Investing Cash Flow |
0.00 | 2.58B | -15.95B | -5.17B | -4.01B | -3.84B | Financing Cash Flow |
0.00 | -11.49B | 6.84B | -3.35B | -2.41B | -2.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $883.89B | 9.99 | 13.60% | 3.77% | 7.52% | 19.95% | |
71 Outperform | ¥105.06B | 9.14 | 7.86% | 3.61% | -0.32% | 10.52% | |
68 Neutral | ¥75.92B | 6.96 | 5.58% | 0.28% | -24.90% | ||
66 Neutral | $437.79B | 6.66 | 11.45% | 1.96% | 4.44% | 409.76% | |
66 Neutral | $130.64B | 11.70 | 5.97% | 2.91% | -0.22% | 76.75% | |
66 Neutral | $495.61B | 10.61 | 6.79% | 3.63% | 7.97% | 31.70% | |
63 Neutral | $4.27B | 11.40 | 5.38% | 214.63% | 4.11% | -8.98% |